Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

CRM1/XPO1-FOXO1 Pathway Is Associated with Clinical Outcome and Represents a Promising Target in B-Cell Acute Lymphocytic Leukemia

Shiyu Deng, Jiawang Ou, Cai Zihong, Zicong Huang, Jia Li, Qifa Liu, Hongsheng Zhou

Blood (2023) 142 (Supplement 1): 4253.

https://doi.org/10.1182/blood-2023-188459

Published: 2023

Journal Articles

A Retrospective Analysis on the Efficacy and Saftey of Obinutuzumab in the Treatment of Non-Hodgkin B Cell Lymphoma

Yangzhi Zhao, Wei Guo, Jia Li, Xingtong Wang, Xin Wan, Junna Li, Ou Bai

Blood (2023) 142 (Supplement 1): 4427.

https://doi.org/10.1182/blood-2023-187801

Published: 2023

Journal Articles

A Multicenter, Prospective Clinical Study of the R-CDOP Regimen in Previously Untreated Non-Hodgkin Lymphoma with High Tumor Burden

Wei Guo, Xingtong Wang, Yangzhi Zhao, Jia Li, Chunshui Liu, Xin Wan, Ou Bai

Blood (2023) 142 (Supplement 1): 1736.

https://doi.org/10.1182/blood-2023-188580

Published: 2023

Journal Articles

Lenalidomide in Combination with Etoposide Induced Ferroptotic Cell Death in DLBCL

Jia Li, Wei Guo, Yangzhi Zhao, Xingtong Wang, Xin Wan, Ou Bai

Blood (2023) 142 (Supplement 1): 5788.

https://doi.org/10.1182/blood-2023-186912

Published: 2023

Journal Articles

The Combination of Pegfilgrastim and Filgrastim Improves the Outcomes of Mobilization and Engraftment after Transplantation of Autologous Hematopoietic Stem Cells for the Treatment of Lymphoma

Xingtong Wang, Wei Guo, Yangzhi Zhao, Jia Li, Xin Wan, Ou Bai

Blood (2023) 142 (Supplement 1): 4891.

https://doi.org/10.1182/blood-2023-182840

Published: 2023

Journal Articles

Introduction of Glofitamab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after ≥2 Lines of Systemic Therapy Results in Cost Savings to the Healthcare System Based on a United States Budget Impact Analysis

Zahra Mahmoudjafari, Jia Li, Eric Bercaw, Hélène Parisé, Katalin Bognar, Si-Tien Wang, Anthony Masaquel

Blood (2023) 142 (Supplement 1): 7246.

https://doi.org/10.1182/blood-2023-174218

Published: 2023

Journal Articles

A Phase I Study of CD19-Targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jae H. Park, Maria Lia Palomba, Sean M. Devlin, Yannis K. Valtis, Devanjan S Sikder, Brigitte Senechal, Xiuyan Wang, Elizabeth Cathcart, Kelly Liotta, Alina Yu, Kelsey Stocker, Honglei Zhang, Heiko Schoder, Doris Leithner, Jia Li, Leopold Sellner, Jorge Mansilla-Soto, Isabelle Riviere, Michel Sadelain

Blood (2023) 142 (Supplement 1): 892.

https://doi.org/10.1182/blood-2023-187623

Published: 2023

Journal Articles

Glofitamab Results in Cost Savings Versus Epcoritamab in Diffuse Large B-Cell Lymphoma (DLBCL): A Total Cost of Care Analysis

Zahra Mahmoudjafari, Danilo Di Maio, Jia Li, Katherine L. Rosettie, Anthony Masaquel

Blood (2023) 142 (Supplement 1): 3703.

https://doi.org/10.1182/blood-2023-174918

Published: 2023

Journal Articles

TET2-Mediated Dysregulation of Heterochromatin in Age-Related Clonal Hematopoiesis

Tingting Hong, Jia Li, Lei Guo, Maryn Cavalier, Tianlu Wang, Shaohai Fang, Anna Guzman, Katharina Wohlan, Chiraag Kapadia, Yaling Yang, C. Cameron Yin, Shaoying Li, M. James You, Xiaodong Cheng, Yubin Zhou, Margaret Goodell, Yun Nancy Huang

Blood (2023) 142 (Supplement 1): 5606.

https://doi.org/10.1182/blood-2023-178792

Published: 2023

Journal Articles

A Phase I Study of CD19-Targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Jae H Park, M. Lia Palomba, Isabelle Rivière, Devanjan S. Sikder, Brigitte Senechal, Xiuyan Wang, Vladimir P. Bermudez, Elizabeth R. Cathcart, Kelly Liotta, Jannakie Joseph, Jia Li, Yunqi Zhao, Rachael Liu, Sharon Chen, Leopold Sellner, Michel Sadelain

Blood (2022) 140 (Supplement 1): 403–404.

https://doi.org/10.1182/blood-2022-168206

Published: 2022

Journal Articles

The Clinical and Translational Exploration of the Role of S1P/SPHK1 Pathway in Non-Hodgkin Lymphoma with Obesity

Xingtong Wang, Wei Guo, Xiaoju Shi, Jia Li, Min Tan, Yan Li, Ou Bai

Blood (2022) 140 (Supplement 1): 9249–9250.

https://doi.org/10.1182/blood-2022-169371

Published: 2022

Journal Articles

Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Justin Gatwood, Anthony Masaquel, Ryan Ross, Danny Sheinson, Farah Hossain, Jia Li, Cameron James, David Fox

Blood (2022) 140 (Supplement 1): 7906–7907.

https://doi.org/10.1182/blood-2022-157905

Published: 2022

Journal Articles

The Short-Term Efficacy and Safety of Obinutuzumab Plus Chemotherapy in B-NHL with High Tumor Burden: A Real-World, Retrospective Study

Xin Wan, Wei Guo, Xingtong Wang, Yangzhi Zhao, Jia Li, Junna Li, Zhumei Zhan, Ou Bai

Blood (2022) 140 (Supplement 1): 11977–11978.

https://doi.org/10.1182/blood-2022-169343

Published: 2022

Journal Articles

Clinical Features and Prognosis of Double Primary Malignant Neoplasms in Patients with Non-Hodgkin Lymphoma

Zhumei Zhan, Wei Guo, Xingtong Wang, Jia Li, Xin Wan, Ou Bai

Blood (2022) 140 (Supplement 1): 11968–11969.

https://doi.org/10.1182/blood-2022-169463

Published: 2022

Journal Articles

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Wei Guo, Yangzhi Zhao, Xingtong Wang, Jia Li, Qiang Guo, Junna Li, Ken H. Young, Ou Bai

Blood (2021) 138 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2021-152164

Published: 2021

Journal Articles

Cost of Disease Progression after Frontline (1L) R-CHOP in Diffuse Large B-Cell Lymphoma (DLBCL)

Rongrong Wang, Josh Roth, Carmen Ng, Farah Hossain, Jia Li, Anthony Masaquel

Blood (2021) 138 (Supplement 1): 3002.

https://doi.org/10.1182/blood-2021-146802

Published: 2021

Journal Articles

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Wei Guo, Xiaomeng Feng, Yinping Wang, Jia Li, Yangzhi Zhao, Limei Qu, Xu Yan, Junna Li, Qiang Guo, Ken H. Young, Ou Bai

Blood (2021) 138 (Supplement 1): 4563.

https://doi.org/10.1182/blood-2021-147695

Published: 2021

Journal Articles

Tet2 Inactivation Enhances the Anti-Tumor Activity of Tumor-Infiltrating Lymphocytes (TILs) to Curtail Melanoma Growth

Minjung Lee, PhD, Jianfang Li, PhD, Shaohai Fang, MS, Joanna Zhang, Anh Tran Tram Vo, Wei Han, MS, Hongxiang Zeng, PhD, Sevinj Isgandarova, Margarita Martinez Moczygemba, PhD, Yubin Zhou, PhD, Jia Li, PhD, Deqiang Sun, PhD, Yun Huang, PhD

Blood (2020) 136 (Supplement 1): 27.

https://doi.org/10.1182/blood-2020-137242

Published: 2020

Journal Articles

ZRSR1 Cooperates with ZRSR2 in Regulating Splicing of U12-Type Introns in Murine Hematopoietic Cells

Zeya Cao, Vikas Madan, PhD, Weoi Woon Teoh, Pushkar Dakle, Lin Han, PhD, Pavithra Shyamsunder, Siqin Zhou, Jia Li, PhD, Hazimah Binte Mohd Nordin, Shi Jizhong, Yu Shuizhou, Henry Yang, PhD, Md Zakir Hossain, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, H. Phillip Koeffler, MD

Blood (2020) 136 (Supplement 1): 22.

https://doi.org/10.1182/blood-2020-136071

Published: 2020

Journal Articles

Highly-Sensitive DNA Hydroxymethylation Analysis in Myelodysplastic Syndromes (MDS)

Jia Li, PhD, Yue Wei, PhD, Minjung Lee, Hui Yang, MD PhD, Caleb Class, PhD, Stefan Siwko, Yubin Zhou, PhD, Deqiang Sun, PhD, Guillermo Garcia-Manero, MD, Yun Huang, PhD

Blood (2020) 136 (Supplement 1): 17.

https://doi.org/10.1182/blood-2020-137733

Published: 2020

NARROW

CRM1/XPO1-FOXO1 Pathway Is Associated with Clinical Outcome and Represents a Promising Target in B-Cell Acute Lymphocytic Leukemia

A Retrospective Analysis on the Efficacy and Saftey of Obinutuzumab in the Treatment of Non-Hodgkin B Cell Lymphoma

A Multicenter, Prospective Clinical Study of the R-CDOP Regimen in Previously Untreated Non-Hodgkin Lymphoma with High Tumor Burden

Lenalidomide in Combination with Etoposide Induced Ferroptotic Cell Death in DLBCL

The Combination of Pegfilgrastim and Filgrastim Improves the Outcomes of Mobilization and Engraftment after Transplantation of Autologous Hematopoietic Stem Cells for the Treatment of Lymphoma

Introduction of Glofitamab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after ≥2 Lines of Systemic Therapy Results in Cost Savings to the Healthcare System Based on a United States Budget Impact Analysis

A Phase I Study of CD19-Targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Glofitamab Results in Cost Savings Versus Epcoritamab in Diffuse Large B-Cell Lymphoma (DLBCL): A Total Cost of Care Analysis

TET2-Mediated Dysregulation of Heterochromatin in Age-Related Clonal Hematopoiesis

A Phase I Study of CD19-Targeted 19(T2)28z1xx CAR T Cells in Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

The Clinical and Translational Exploration of the Role of S1P/SPHK1 Pathway in Non-Hodgkin Lymphoma with Obesity

Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

The Short-Term Efficacy and Safety of Obinutuzumab Plus Chemotherapy in B-NHL with High Tumor Burden: A Real-World, Retrospective Study

Clinical Features and Prognosis of Double Primary Malignant Neoplasms in Patients with Non-Hodgkin Lymphoma

Chidamide Maintenance Therapy after Induction or Salvage Treatment in Patients with Peripheral T-Cell Lymphoma Ineligible for Autologous Stem Cell Transplantation

Cost of Disease Progression after Frontline (1L) R-CHOP in Diffuse Large B-Cell Lymphoma (DLBCL)

The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone Acetate in Peripheral T Cell Lymphomas: A Real-World, Retrospective Case Series from China

Tet2 Inactivation Enhances the Anti-Tumor Activity of Tumor-Infiltrating Lymphocytes (TILs) to Curtail Melanoma Growth

ZRSR1 Cooperates with ZRSR2 in Regulating Splicing of U12-Type Introns in Murine Hematopoietic Cells

Highly-Sensitive DNA Hydroxymethylation Analysis in Myelodysplastic Syndromes (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only